Tema Heart & Health ETF (NASDAQ:HRTS) Sees Large Drop in Short Interest

Tema Heart & Health ETF (NASDAQ:HRTS) was the target of a significant drop in short interest in August. As of August 14th, there was short interest totaling 2,508 shares, a drop of 50.8% from the July 30th total of 5,095 shares. Based on an average daily trading volume, of 3,207 shares, the days-to-cover ratio is currently 0.8 days. Currently, 0.2% of the shares of the stock are short sold.

Tema Heart & Health ETF Trading Down 1.1%

NASDAQ:HRTS traded down $0.42 during mid-day trading on Friday, reaching $37.64. 3,797 shares of the stock were exchanged, compared to its average volume of 5,984. The business has a fifty day moving average price of $36.89 and a 200 day moving average price of $35.15. Tema Heart & Health ETF has a 1-year low of $29.45 and a 1-year high of $38.87. The firm has a market capitalization of $56.08 million, a PE ratio of 22.06 and a beta of 0.63.

Hedge Funds Weigh In On Tema Heart & Health ETF

Several large investors have recently made changes to their positions in the business. Kestra Advisory Services LLC bought a new stake in shares of Tema Heart & Health ETF in the 4th quarter worth approximately $27,000. JPMorgan Chase & Co. acquired a new stake in shares of Tema Heart & Health ETF during the 2nd quarter valued at $63,000. Citadel Advisors LLC acquired a new stake in shares of Tema Heart & Health ETF during the 3rd quarter valued at $243,000. XML Financial LLC bought a new stake in shares of Tema Heart & Health ETF during the 2nd quarter worth $223,000. Finally, Anson Capital Inc. bought a new stake in shares of Tema Heart & Health ETF during the 2nd quarter worth $297,000.

About Tema Heart & Health ETF

The Tema Obesity & Cardiometabolic ETF (HRTS) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that concentrates on companies focused on the treatment of cardiovascular diseases and/or metabolic diseases from companies all around the world. Using both top-down and bottom-up stock selection, the fund identifies innovative companies deemed attractive. HRTS was launched on Nov 20, 2023 and is issued by Tema.